Market revenue in 2023 | USD 839.2 million |
Market revenue in 2030 | USD 815.5 million |
Growth rate | -0.4% (CAGR from 2023 to 2030) |
Largest segment | Conventional pcr |
Fastest growing segment | Conventional PCR |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Conventional PCR |
Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Qiagen NV, Roche Holding AG ADR, Standard BioTools Inc, Stilla, Microsynth |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to polymerase chain reaction market will help companies and investors design strategic landscapes.
Conventional pcr was the largest segment with a revenue share of 9.96% in 2023. Horizon Databook has segmented the Japan polymerase chain reaction market based on conventional pcr covering the revenue growth of each sub-segment from 2018 to 2030.
Growth in the market is driven by the increasing prevalence of target diseases, growing awareness regarding the early disease diagnosis and rising geriatric population. Japan has a well-established public healthcare system, trained public health workers, and enhanced healthcare services in educational centers.
These factors are contributing to the reduced mortality rate of infectious diseases. The rising prevalence of infectious diseases is expected to impede economic and social advancement in Japan. Owing to the increasing need for improved disease management, Japan’s PCR market is expected to exhibit steady growth over the forecast period.
Moreover, researchers are engaged in the development of cheaper alternatives for the detection of diseases. Biohackers and researchers in Keio University’s Institute of Advanced Life Sciences, with the collaboration of Tokyo BioClub, are developing a new real-time kit, Ninja qPCR, at a low cost of around USD 300.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan polymerase chain reaction market , including forecasts for subscribers. This country databook contains high-level insights into Japan polymerase chain reaction market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account